Cochlear Limited Gets FDA Approval for Nucleus 5

Published: Sep 08, 2009

Bookmark and Share

Pharmabiz.com -- Cochlear Limited, the global leader in cochlear and bone conduction implant technology, announced that it will launch three new technologies - Cochlear Nucleus 5, Cochlear Baha BP100 and Cochlear Hybrid - in India within a month. Trials of these products were already conducted over the period of 10 years in India. Already 3500 hearing impaired patients are the recipients of these implant technologies in the country.

Back to news